© 2021 BioMarin. All rights reserved.
| Beta | 0.53 |
|---|---|
| Shares Outstanding | 183.4M |
| Average Volume (10 days) | 1.2M |
| Qtrly Dividend (Ann. Yield) | -- (--) |
| Earnings (TTM) | $4.31 |
|---|---|
| Sales (TTM) | $10.45 |
| Book Value (MRQ) | $23.13 |
| Cash Flow (TTM) | $1.40 |
| Cash (MRQ) | $6.14 |
| Current Mean Recommendation | Buy |
|---|
| Strong Buy | 11 | |
|---|---|---|
| Buy | 0 | |
| Hold | 4 | |
| Underperform | 0 | |
| Sell | 0 |
G. Eric Davis EVP, General Counsel | (5,518) Sell Aug 2, 2021 |
|---|---|
Andrea Acosta GVP, Chief Accounting Officer | (285) Dispose Jul 16, 2021 |
Brian Mueller EVP, Chief Financial Officer | (576) Dispose Jun 29, 2021 |
Brian Mueller EVP, Chief Financial Officer | (6,709) Sell May 7, 2021 |
Jean-Jacques Bienaime Director, Chief Executive Officer | (15,556) Sell May 7, 2021 |